The order, signed in October 2023, required companies building powerful AI systems to share their safety test results with ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.

AI creatives with access to Google’s Veo 2 text-to-video tool say it’s another “leap forward” for video generation Veo 2 ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

Demis Hassabis is the CEO of Google DeepMind. Demis thinks new agent type systems will be able to perform additional tree of knowledge search to achieve ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

The company fulfilled requests from Israel’s military for more access to AI tools as it sought to compete with Amazon, ...

Google DeepMind AI for Science Scholarships are now available, offering African students the opportunity to pursue ...

Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

Researchers are identifying current and future dangers within AI models away from the conflicts of interest they’d face in ...

Google DeepMind Chief Operations Officer Lila Ibrahim discussed the changes that the Trump administration may bring, ...